Quarterly Earnings

Events

Investor Relations

Press Releases

17 Feb '26
CHICAGO --(BUSINESS WIRE)--Feb. 17, 2026-- Veradigm ®   (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026.
02 Feb '26
CHICAGO --(BUSINESS WIRE)--Feb. 2, 2026-- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to

Stock Information

Minimum 15 minutes delayed. Source: LSEG

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com